Table 5.

Summary measures for the optimal threshold obtained across iterations in the cross-validation are shown for T1 lesions (T1L) and T2 lesions (T2L).

Lesion Type	Mean	Std. Dev.	Min, Max
T1L	0.28	0.05	0.2, 0.36
T2L	0.32	0.04	0.25, 0.39